{"id":"NCT00327444","sponsor":"Sanofi","briefTitle":"Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites","officialTitle":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Effect of Intravenous Aflibercept Administered Every 2 Weeks in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-07","primaryCompletion":"2009-10","completion":"2009-10","firstPosted":"2006-05-18","resultsPosted":"2013-01-01","lastUpdate":"2013-01-01"},"enrollment":58,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Ovarian Neoplasms","Ascites"],"interventions":[{"type":"DRUG","name":"aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Aflibercept","type":"EXPERIMENTAL"}],"summary":"This study was designed to characterize the effect of aflibercept in participants with advanced chemoresistant ovarian cancer.\n\nPrimary objective: Compare the effect of aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®) to placebo treatment on repeat paracentesis in symptomatic malignant ascites in participants with advanced ovarian cancer\n\nSecondary objectives: Safety, tolerability, paracentesis-related parameters, participant-reported outcome.","primaryOutcome":{"measure":"Time to Repeat Paracentesis (TRP)","timeFrame":"From Day 1 up to 6 months from randomization","effectByArm":[{"arm":"Placebo","deltaMin":23.3,"sd":7.7},{"arm":"Aflibercept","deltaMin":55.1,"sd":7.25}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0019"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":9,"countries":["United States","Austria","Belgium","Canada","Hungary","India","Israel","Spain","United Kingdom"]},"refs":{"pmids":["37185961","22192729"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":25},"commonTop":["Vomiting","Fatigue","Oedema peripheral","Nausea","Diarrhoea"]}}